arrow
R

Rebecca J. Rockett

university of sydney and westmead hospital
H指数:28
被引数:2,797

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification and genomic characterisation of BA.3.2: a highly divergent BA.3-related SARS-CoV-2 lineage from southern Africa

BA.3.2的鉴定及基因组特征分析:一种来自南部非洲的高度分化的BA.3相关SARS-CoV-2谱系

2026-03-180
OA
Genomic Evolution of SARS-CoV-2 Variants of Concern Under In Vitro Neutralising Selection Pressure Following Two Doses of the Pfizer-BioNTech BNT162b2 COVID-19 Vaccine

SARS-CoV-2受关注变体在体外中和选择压力下的基因组进化:继辉瑞-BioNTech BNT162b2 COVID-19疫苗两剂接种之后

2025-08-280
OA
Recurrent integration of domestic cat hepatitis B virus DNA near feline CCNE1 supports an oncogenic role in hepatocellular carcinoma in cats

家猫乙型肝炎病毒DNA在猫CCNE1附近的复发整合,支持其在猫肝细胞癌中的致癌作用

2025-07-160
OAAI
Novel digital droplet inverse PCR assay shows that natural clearance of hepatitis B infection is associated with fewer viral integrations

新型数字液滴反向PCR检测方法表明,乙型肝炎病毒感染的自然清除与病毒整合较少相关。

2025-01-130
OA
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants

二价Omicron BA.1疫苗加强剂增加记忆b细胞宽度并中和针对新兴SARS-CoV-2变体的抗体

2024-12-010
OAAI
A laboratory framework for ongoing optimization of amplification-based genomic surveillance programs

用于持续优化基于扩增的基因组监视程序的实验室框架

2023-12-121
OAAI
Advancing pathogen genomics in resource-limited settings
2023-12-018
OAAI
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine
2022-09-137
OAAI
Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance
2022-05-1850
OAAI
Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use
2022-04-14131
OAAI